PSPC1 knockout slows AML in preclinical models
Scientists at UT Health San Antonio have identified PSPC1 in…
Scientists at UT Health San Antonio have identified PSPC1 in mouse models as a promising new drug target for acute myeloid leukaemia (AML), a deadly blood cancer with limited treatment options.